-
Anderson S L, Carton J M, Lou J. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus[J]. Virology, 1999, 256(1): 8-14. doi: 10.1006/viro.1999.9614
-
Bourne H R, Sanders D A, McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions[J]. Nature, 1990, 348(6297): 125-132. doi: 10.1038/348125a0
-
Bourne H R, Sanders D A, McCormick F. The GTPase superfamily: conserved structure and molecular mechanism[J]. Nature, 1991, 349(6305): 117-127. doi: 10.1038/349117a0
-
Cheng Y S, Becker-Manley M F, Chow T P. Affinity purification of an interferon-induced human guanylate-binding protein and its characterization[J]. J Biol Chem, 1985, 260(29): 15834-15839.
-
Cheng Y S, Patterson C E, Staeheli P. Interferon-induced guanylate-binding proteins lack an N (T)KXD consensus motif and bind GMP in addition to GDP and GTP[J]. Mol Cell Biol, 1991, 11(9): 4717-4725. doi: 10.1128/MCB.11.9.4717
-
Frese M, Kochs G, Feldmann H. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein[J]. J Virol Methods, 1996, 70(2): 915-923.
-
Ghosh A, Praefcke G J, Renault L. How guanylate-binding proteins achieve assembly-stimulated processive cleavage of GTP to GMP[J]. Nature, 2006, 440(7080): 101-104. doi: 10.1038/nature04510
-
Guidotti L G, Morris A, Mendez H. Interferon-regulated pathways that control hepatitis B virus replicationin transgenic mice[J]. J Virol, 2002, 76(): 2617-2621. doi: 10.1128/JVI.76.6.2617-2621.2002
-
Kunzelmann S, Praefcke G J, Herrmann C. Nucleotide binding and self-stimulated GTPase activity of human guanylate-binding protein 1 (hGBP1)[J]. Methods Enzymol, 2005, 404(): 512-527. doi: 10.1016/S0076-6879(05)04045-0
-
Lu Y P, Wang B J, Dong J H. Construction and Characterization of a Hepatitis B Virus Replicon[J]. Virologica Sinica, 2007, 22(1): 8-13. doi: 10.1007/s12250-007-0055-7
-
Lubeseder-Martellato C, Guenzi E, Jorg A. Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases[J]. Am J Pathol, 2002, 161(5): 1749-1751. doi: 10.1016/S0002-9440(10)64452-5
-
Marschall M, Zach A, Hechtfischer A. Inhibition of influenza C viruses by human MxA protein[J]. Virus Res, 2000, 67(2): 179-188. doi: 10.1016/S0168-1702(00)00140-4
-
Modiano N, Lu Y E, Cresswell P. Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-gamma-inducible cofactor[J]. Proc Natl Acad Sci USA, 2005, 102(24): 8680-8685. doi: 10.1073/pnas.0503227102
-
Naschberger E, Bauer M, Sturzl M. Human guanylate binding protein-1 (hGBP-1) characterizes and establishes a non-angiogenic endothelial cell activation phenotype in inflammatory diseases[J]. Adv Enzyme Regul, 2005, 45(): 215-227. doi: 10.1016/j.advenzreg.2005.02.011
-
Samuel C E. Antivirus actions of interferon[J]. Clin Microbiol Rev, 2001, 14(4): 778-809. doi: 10.1128/CMR.14.4.778-809.2001
-
Schanen C, Chieux V, Lobert P E. Correlation between the anti-virus-induced cytopathic effect activity of interferon-alpha subtypes and induction of MxA protein in vitro[J]. Microbiol Immunol, 2006, 50(1): 19-24. doi: 10.1111/mim.2006.50.issue-1